Cardiac remodeling is triggered in response to mechanical stress and various neurohumoral factors. We have recently discovered that protein kinase D (PKD), which has been scarcely studied in cardiomyocytes, plays a significant role to regulate cardiac hypertrophy and remodeling in the downstream of Gq-coupling receptor (GqPCR) -protein kinase C (PKC) signaling. Furthermore, we have identified that a muscle restricted PDZ-3LIM protein, ENH1, has a unique function to selectively and directly bind to PKC and PKD and segregate this kinase complex to cardiac Z-disc, which has been thought as a central machinery of mechanical stress signaling. Based on these observations, we hypothesize that the PKCr ENH1-PKD1 complex plays a critical role in the regulation of cardiac hypertrophy and remodeling by integrating GqPCR signaling and mechanical stress signaling. In this proposal, we will test this hypothesis using a combinatory strategy of genetically modified mouse models and in vivo physiological analysis. The research focuses on in vivo analysis of the relationship between the mechanical stress-induced cardiac remodeling and the PKC-ENH1-PKD1 signal complex. Accordingly, our specific aims are: 1) to characterize in vivo activation of PKD in the process of cardiac remodeling in animal models of cardiac hypertrophy and failure, 2) to generate and characterize cardiac transgenic mice with constitutive active and dominant negative mutants of PKD, 3) to test ENH-null hearts and cardiomyocytes to define the physiological roles of ENH in cardiac mechanical stress signaling, and 4) to examine potential downstream target molecules of PKC-ENH-PKD signaling in cardiac remodeling. We anticipate that the outcome of these studies will assist our better understanding of molecular mechanisms that determine the fate of stressed cardiomyocytes and help to design new drug to induce favorable remodeling in diseased hearts.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL081401-03
Application #
7268618
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Schwartz, Lisa
Project Start
2005-09-01
Project End
2010-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
3
Fiscal Year
2007
Total Cost
$366,235
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hoshijima, Masahiko; Hayashi, Takeharu; Jeon, Young E et al. (2011) Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters. Circ Heart Fail 4:89-97
Kitajima, Naoyuki; Watanabe, Kunihiro; Morimoto, Sachio et al. (2011) TRPC3-mediated Ca2+ influx contributes to Rac1-mediated production of reactive oxygen species in MLP-deficient mouse hearts. Biochem Biophys Res Commun 409:108-13
Powell, Frank L; Kim, B Cindy; Johnson, S Randall et al. (2009) Oxygen sensing in the brain--invited article. Adv Exp Med Biol 648:369-76
Raskin, Anna M; Hoshijima, Masahiko; Swanson, Eric et al. (2009) Hypertrophic gene expression induced by chronic stretch of excised mouse heart muscle. Mol Cell Biomech 6:145-59
Hoshijima, Masahiko (2006) Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 290:H1313-25
Hoshijima, Masahiko; Knoll, Ralph; Pashmforoush, Mohammad et al. (2006) Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. J Am Coll Cardiol 48:A15-23
Iwata, Miki; Maturana, Andres; Hoshijima, Masahiko et al. (2005) PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Biochem Biophys Res Commun 327:1105-13